Catherine M. Burzik - 21 Jun 2021 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Kimberley A. Elting, Chief Legal and Development Officer, by power of attorney
Issuer symbol
OFIX
Transactions as of
21 Jun 2021
Net transactions value
$0
Form type
4
Filing time
23 Jun 2021, 16:45:03 UTC
Previous filing
25 Jan 2024
Next filing
09 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $0 +5,976 $0.000000 5,976 21 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OFIX Stock Option (right to buy) Award $0 +21,361 $0.000000 21,361 21 Jun 2021 Common Stock 21,361 $40.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 21, 2021.
F2 These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 21, 2021.